Serotonin production in lymphocytes and mercury intolerance

Toxicology in Vitro

Volumn 14, Issue 2, 2000, Pages 133-137

  Marcusson, J A ^a   Cederbrant, K ^b   Gunnarsson, L G ^c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b ASTRAZENECA R AND D   (Sweden)

^c ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

Dental amalgam; Intolerance; Mercury; Serotonin

Indexed keywords

AMALGAM; MERCURY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; LYMPHOCYTE; MALE; MERCURIALISM; PSYCHOLOGIC ASSESSMENT; PSYCHOSOMATICS; SEROTONIN RELEASE;

ADULT; AGED; ALGORITHMS; COCULTURE TECHNIQUES; DENTAL AMALGAM; FEMALE; HUMANS; LYMPHOCYTES; MALE; MERCURIC CHLORIDE; MERCURY POISONING; MIDDLE AGED; PHENYLMERCURIC ACETATE; PSYCHOPHYSIOLOGIC DISORDERS; SEROTONIN;

EID: 0033994134     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(00)00008-4     Document Type: Article

References (21)

1. Aune T.M., Golden H.W., McGrath K.M. Inhibition of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediatd immunity in vivo. Journal of Immunology. 153:1994;489-498.
2. Aune T.M., McGrath K.M., Sarr T., Bombara M.P., Kelley K.A. Expression of 5H1a Receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. Journal of Immunology. 151:1993;1175-1183.
3. Axell T., Björkner B., Fregert S., Niklasson B. Standard patch test series for screening of contact allergy to dental materials. Contact Dermatitis. 9:1983;82-84.
4. Baskys A. and Remington G. (1996) Serotonin and dopamine as neurotransmitters. In Brain Mechanisms and Psychotropic Drugs, pp. 55-71. CRC Press.
5. Baumgarten H.G., Grozdanovic Z. Psychopharmacology of central serotonergic systems. Pharmacopsychiatry. 28:1995;73-79.
6. Bondesson L., Nordlind K., Liden S., Sundström E. Inhibiting effects of serotonin and serotonin antagonists on the migration of mononuclear leucocytes. Immunopharmacology Immunotoxicology. 15:1993;243-250.
7. Dahlöf C. Minor symptom evaluation (MSE) profile - a questionnaire for assessment of subjective CNS related symptoms. Scandinavian Journal of Primary Health Care Suppl. 1:1990;19-25.
8. Juan M.S., Yonemura K. Increased spontaneous transmitter release from presynaptic nerve terminal by methylmercuric chloride. Nature. 256:1975;211-213.
9. Juang M.S. An electrophysiological study of the action of methylmercuric chloride and mercuric chloride on the sciatic nerve-sartorius muscle preparation on the frog. Toxicology and Applied Pharmacology. 37:1976;339-348.
10. Kirk A.R. Experimental Design: Procedures for the Behaviour Sciences. 1995;Brools-Cole, Pacific Grove.
11. Komulainen H., Tuomisto J. Interference of methyl mercury with monoamine uptake and release in rat brain synaptosomes. Acta Pharmacologia et Toxicologia. 48:1981;214-222.
12. Marcusson J.A. Psychological and somatic subjective symptoms as a result of dermatological patch testing with metallic mercury and phenyl mercuric acetate. Toxicology Letters. 84:1996;113-122.
13. Marcusson J.A., Jarstrand C. Oxidative metabolism of neutrophils in vitro and human mercury intolerance. Toxicology in Vitro. 12:1998;383-388.
14. Mills K.C. Serotonin syndrome. Medical Toxicology. 13:1997;763-783.
15. Nakazato Y., Asano T., Ohga A. The in vitro effect of mercury compounds on noradrenaline output from guinea pig vas deferens. Toxicology and Applied Pharmacology. 48:1979;171-177.
16. Nylander M. (1990) Accumulation and biotransformation of mercury and its relationship to selenium after exposure to inorganic mercury and methylmercury. A study on individuals with amalgam fillings, dental personnel and monkeys. PhD thesis, Karolinska Institute, Stockholm.
17. O'Kusky J.R., Boyes B.E., McGeer E.G. Methyl mercury-induced movement and postural disorders in developing rat; regional analysis of brain catecholamines and indole amines. Brain Research. 439:1988;138-146.
18. Oudar P. In vitro effect of organic and inorganic mercury on the serotonergic system. Pharmacology and Toxicology. 65:1989;245-248.
19. Pirälä V. Chamber test versus patch test for epicutaneous testing. Contact Dermatitis. 1:1975;48-52.
20. Skerving, S. and Scütz, A. (1992) Occupational exposure to mercury. In Potential Biological Consequences of Mercury Released from Dental Amalgam, pp. 147-162. Swedish Medical Research Council.
21. Vimy J. M. and Lorscheider F. L. (1992) Amalgam mercury tissue distribution and potential pathophysiology. In Potential Biological Consequences of Mercury Released from Dental Amalgam, pp. 191-199. Swedish Medical Research Council.